Allan Gaw
Allan Gaw
Professor, Queen's University Belfast
Ingen verifierad e-postadress
Titel
Citeras av
Citeras av
År
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd, GJ Blauw, MB Murphy, ELEM Bollen, BM Buckley, SM Cobbe, ...
The Lancet 360 (9346), 1623-1630, 2002
40552002
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O’Reilly, SM Haffner, C Isles, ...
Circulation 108 (4), 414-419, 2003
19222003
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
DJ Freeman, J Norrie, N Sattar, RDG Neely, SM Cobbe, I Ford, C Isles, ...
Circulation 103 (3), 357-362, 2001
11692001
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)
AM Wallace, AD McMahon, CJ Packard, A Kelly, J Shepherd, A Gaw, ...
Circulation 104 (25), 3052-3056, 2001
10972001
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
DJ Freeman, J Norrie, MJ Caslake, A Gaw, I Ford, GDO Lowe, ...
Diabetes 51 (5), 1596-1600, 2002
10122002
The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
J Shepherd, GJ Blauw, MB Murphy, SM Cobbe, ELEM Bollen, BM Buckley, ...
The American journal of cardiology 84 (10), 1192-1197, 1999
3231999
The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
J Shepherd, GJ Blauw, MB Murphy, A Gaw
The design 84, 1192-1197, 1999
2631999
Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre‐eclampsia
N Sattar, A Gaw, CJ Packard, IA Greer
BJOG: An International Journal of Obstetrics & Gynaecology 103 (7), 614-620, 1996
2051996
Clinical Biochemistry E-Book: An Illustrated Colour Text
A Gaw, M Murphy, R Srivastava, RA Cowan, DSJ O'Reilly
Elsevier Health Sciences, 2013
1752013
Testing cognitive function in elderly populations: the PROSPER study
PJ Houx, J Shepherd, GJ Blauw, MB Murphy, I Ford, EL Bollen, B Buckley, ...
Journal of Neurology, Neurosurgery & Psychiatry 73 (4), 385-389, 2002
1552002
Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.
MJ Caslake, CJ Packard, A Gaw, E Murray, BA Griffin, BD Vallance, ...
Arteriosclerosis and thrombosis: a journal of vascular biology 13 (5), 702-711, 1993
1551993
CLINICAL PERSPECTIVE
N Sattar, HM Murray, A McConnachie, GJ Blauw, ELEM Bollen, ...
Circulation 115 (8), 981-989, 2007
1482007
Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults
CJ Packard, RGJ Westendorp, DJ Stott, MJ Caslake, HM Murray, ...
Journal of the American Geriatrics Society 55 (11), 1777-1785, 2007
1472007
Comparative analysis of the apo (a) gene, apo (a) glycoprotein, and plasma concentrations of Lp (a) in three ethnic groups. Evidence for no common" null" allele at the apo (a …
A Gaw, E Boerwinkle, JC Cohen, HH Hobbs
Journal of Clinical Investigation 93 (6), 2526, 1994
1461994
West of Scotland Coronary Prevention Study: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
DJ Freeman
Diabetes 51, 1596-1600, 2002
1422002
Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
A Gaw, CJ Packard, EF Murray, GM Lindsay, BA Griffin, MJ Caslake, ...
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 13 (2), 170-189, 1993
1411993
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
CJ Packard, I Ford, M Robertson, J Shepherd, GJ Blauw, MB Murphy, ...
Circulation 112 (20), 3058-3065, 2005
1292005
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and …
N Sattar, A McConnachie, I Ford, A Gaw, SJ Cleland, NG Forouhi, ...
Diabetes 56 (4), 984-991, 2007
1212007
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy …
LM Blanco-Colio, JL Martín-Ventura, E de Teresa, C Farsang, A Gaw, ...
American heart journal 153 (5), 881-888, 2007
952007
Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST
LM Blanco-Colio, JL Martín-Ventura, E De Teresa, C Farsang, A Gaw, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (1), 168-174, 2007
80*2007
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20